Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotor urocortin-containing neurons.
paper
Cited
Public
- Authors
- Kaur, Simranjit; Ryabinin, Andrey E
- Year
- 2010
- Journal
- Alcoholism, clinical and experimental research
- PMID
- 20586761
- DOI
- 10.1111/j.1530-0277.2010.01237.x
- PMCID
- PMC2929279
BACKGROUND: The current therapies for alcohol abuse disorders are not effective in all patients, and continued development of pharmacotherapies is needed. One approach that has generated recent interest is the antagonism of ghrelin receptors. Ghrelin is a gut-derived peptide important in energy homeostasis and regulation of hunger. Recent studies have implicated ghrelin in alcoholism, showing altered plasma ghrelin levels in alcoholic patients as well as reduced intakes of alcohol in ghrelin receptor knockout mice and in mice treated with ghrelin receptor antagonists. The aim of this study was to determine the neuroanatomical locus/loci of the effect of ghrelin receptor antagonism on alcohol consumption using the ghrelin receptor antagonist, D-Lys3-GHRP-6. METHODS: In Experiment 1, male C57BL/6J mice were injected with saline 3 hours into the dark cycle and allowed access to 15% (v/v) ethanol or water for 2 hours in a 2-bottle choice experiment. On test day, the mice were injected with either saline or 400 nmol of the ghrelin receptor antagonist, D-Lys3-GHRP-6, and allowed to drink 15% ethanol or water for 4 hours. The preference for alcohol and alcohol intake were determined. In Experiment 2, the same procedure was followed as in Experiment 1 but mice were only allowed access to a single bottle of 20% ethanol (v/v), and alcohol intake was determined. Blood ethanol levels were analyzed, and immunohistochemistry for c-Fos was carried out to investigate changes in neural activity. To further elucidate the mechanism by which D-Lys3-GHRP-6 affects alcohol intake, in Experiment 3, the effect of D-Lys3-GHRP-6 on the neural activation induced by intraperitoneal ethanol was investigated. For the c-Fos studies, brain regions containing ghrelin receptors were analyzed, i.e. the perioculomotor urocortin population of neurons (pIIIu), the ventral tegmental area (VTA), and the arcuate nucleus (Arc). In Experiment 4, to test if blood ethanol concentrations were affected by D-Lys3-GHRP-6, blood samples were taken at 2 time-points after D-Lys3-GHRP-6 pretreatment and systemic ethanol administration. RESULTS: In Experiment 1, D-Lys3-GHRP-6 reduced preference to alcohol and in a follow-up experiment (Experiment 2) also dramatically reduced alcohol intake when compared to saline-treated mice. The resulting blood ethanol concentrations were lower in mice treated with the ghrelin receptor antagonist. Immunohistochemistry for c-Fos showed fewer immunopositive cells in the pIIIu of the antagonist-treated mice but no difference was seen in the VTA or Arc. In Experiment 3, D-Lys3-GHRP-6 reduced the induction of c-Fos by intraperitoneal ethanol in the pIIIu but had no effect in the VTA. In the Arc, there was a significant increase in the number of c-Fos immunopositive cells after D-Lys3-GHRP-6 administration, but the antagonist had no effect on ethanol-induced expression of c-Fos. D-Lys3-GHRP-6-pretreatment also did not affect the blood ethanol concentrations observed after a systemic injection of ethanol when compared to saline-pretreated mice (Experiment 4). CONCLUSIONS: These findings indicate that the action of ghrelin on the regulation of alcohol consumption may occur via the pIIIu.
No figures extracted from this document.
β Prev
21β36 of 36
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| The genetic epidemiology of substance use disorder: A review. | 2017 | 28938182 |
| Stress-related neuropeptides and addictive behaviors: beyond the usual suspects. | 2012 | 23040815 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| An Emerging Role for Gut-Brain Signaling Involving Ghrelin in Chronic Stress. | Salcido AA et al. | β | 2025 | β |
| Evidence for independent actions of the CRF and ghrelin systems in binge-like alcohol drinking in mice. | Richardson RS et al. | β | 2025 | β |
| GHSR blockade, but not reduction of peripherally circulating ghrelin via Ξ²<sub>1</sub>-adrenergic receptor antagonism, decreases binge-like alcohol drinking in mice. | Richardson RS et al. | β | 2025 | β |
| Midbrain ghrelin receptor signalling regulates binge drinking in a sex specific manner. | Pearl AJ et al. | β | 2025 | β |
| The Connection Between the Appetite-Regulatory Peptides Ghrelin and GLP-1 and Alcohol Use Disorder. | Jerlhag E | β | 2025 | β |
| A case control study investigating the methylation levels of GHRL and GHSR genes in alcohol use disorder. | Γzkan-KotiloΔlu S et al. | β | 2024 | β |
| Alcohol and the dopamine system. | SΓΆderpalm B et al. | β | 2024 | β |
| A randomized, double-blind, placebo-controlled study of a GHSR blocker in people with alcohol use disorder. | Faulkner ML et al. | β | 2024 | β |
| Centrally administered growth hormone secretagogue receptor antagonist DLys decreases alcohol intake and preference in male mice. | Richardson RS et al. | β | 2024 | β |
| Des-acyl ghrelin reduces alcohol intake and alcohol-induced reward in rodents. | Witley S et al. | β | 2024 | β |
| Ghrelin system and GLP-1 as potential treatment targets for alcohol use disorder. | Jerlhag E | β | 2024 | β |
| LEAP2, a ghrelin receptor inverse agonist, and its effect on alcohol-related responses in rodents. | Tufvesson-Alm M et al. | β | 2024 | β |
| Animal studies reveal that the ghrelin pathway regulates alcohol-mediated responses. | Jerlhag E | β | 2023 | β |
| Initial Pharmacological Characterization of a Major Hydroxy Metabolite of PF-5190457: Inverse Agonist Activity of PF-6870961 at the Ghrelin Receptor. | Deschaine SL et al. | β | 2023 | β |
| Metabolic hormone action in the VTA: Reward-directed behavior and mechanistic insights. | Geisler CE et al. | β | 2023 | β |
| Pharmacological GHSR (ghrelin receptor) blockade reduces alcohol binge-like drinking in male and female mice. | Richardson RS et al. | β | 2023 | β |
| A closer look at alcohol-induced changes in the ghrelin system: novel insights from preclinical and clinical data. | Deschaine SL et al. | β | 2022 | β |
| Ghrelin mediated regulation of neurosynaptic transmitters in depressive disorders. | Masule MV et al. | β | 2022 | β |
| Insight into the role of the gut-brain axis in alcohol-related responses: Emphasis on GLP-1, amylin, and ghrelin. | Tufvesson-Alm M et al. | β | 2022 | β |
| Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder. | Burnette EM et al. | β | 2022 | β |
| Role of the ghrelin system in alcohol use disorder and alcohol-associated liver disease: A narrative review. | Kharbanda KK et al. | β | 2022 | β |
| A ghrelin receptor antagonist reduces the ability of ghrelin, alcohol or amphetamine to induce a dopamine release in the ventral tegmental area and in nucleus accumbens shell in rats. | Edvardsson CE et al. | β | 2021 | β |
| An Overview of Appetite-Regulatory Peptides in Addiction Processes; From Bench to Bed Side. | Shevchouk OT et al. | β | 2021 | β |
| Gray areas: Neuropeptide circuits linking the Edinger-Westphal and Dorsal Raphe nuclei in addiction. | Pomrenze MB et al. | β | 2021 | β |
| Effects of exogenous ghrelin administration and ghrelin receptor blockade, in combination with alcohol, on peripheral inflammatory markers in heavy-drinking individuals: Results from two human laboratory studies. | Farokhnia M et al. | β | 2020 | β |
| Pursuing the Mechanisms Underlying Alcohol-Induced Changes in the Ghrelin System: New Insights from Preclinical and Clinical Investigations | Farokhnia M et al. | β | 2020 | β |
| The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study. | Lee MR et al. | β | 2020 | β |
| Animal models of binge drinking, current challenges to improve face validity. | Jeanblanc J et al. | β | 2019 | β |
| Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future. | Cannella N et al. | β | 2019 | β |
| Development and validation of an assay for a novel ghrelin receptor inverse agonist PF-5190457 and its major hydroxy metabolite (PF-6870961) by LC-MS/MS in human plasma. | Adusumalli S et al. | β | 2019 | β |
| Effects of leptin and ghrelin on neural cue-reactivity in alcohol addiction: Two streams merge to one river? | Bach P et al. | β | 2019 | β |
| Ghrelin: From a gut hormone to a potential therapeutic target for alcohol use disorder. | Farokhnia M et al. | β | 2019 | β |
| Ghrelin modulates mesolimbic reactivity to alcohol cues in alcohol-addicted subjects: a functional imaging study. | Koopmann A et al. | β | 2019 | β |
| Ghrelin receptor deletion reduces binge-like alcohol drinking in rats. | Zallar LJ et al. | β | 2019 | β |
| NOP Receptor Antagonists Decrease Alcohol Drinking in the Dark in C57BL/6J Mice. | Brunori G et al. | β | 2019 | β |
| Systematic review of the effects of acute stress in binge eating disorder. | Naish KR et al. | β | 2019 | β |
| Investigational drugs for alcohol use disorders: a review of preclinical data. | Ch'Ng SS et al. | β | 2018 | β |
| Medications for alcohol use disorders: An overview. | Akbar M et al. | β | 2018 | β |
| Pharmacological manipulation of the ghrelin system and alcohol hangover symptoms in heavy drinking individuals: Is there a link? | Farokhnia M et al. | β | 2018 | β |
| Roux-en-Y gastric bypass surgery normalizes dopamine D1, D2, and DAT levels. | Hamilton J et al. | β | 2018 | β |
| Stress, Motivation, and the Gut-Brain Axis: A Focus on the Ghrelin System and Alcohol Use Disorder. | Morris LS et al. | β | 2018 | β |
| The impact of the appetite-regulating, orexigenic peptide ghrelin on alcohol use disorders: A systematic review of preclinical and clinical data. | Koopmann A et al. | β | 2018 | β |
| Drinking water to reduce alcohol craving? A randomized controlled study on the impact of ghrelin in mediating the effects of forced water intake in alcohol addiction. | Koopmann A et al. | β | 2017 | β |
| Enhanced alcohol-drinking behavior associated with active ghrelinergic and serotoninergic neurons in the lateral hypothalamus and amygdala. | Yoshimoto K et al. | β | 2017 | β |
| Linking Stress and Infertility: A Novel Role for Ghrelin. | Sominsky L et al. | β | 2017 | β |
| The genetic epidemiology of substance use disorder: A review. | Prom-Wormley EC et al. | β | 2017 | β |
| The gut in the brain: the effects of bariatric surgery on alcohol consumption. | Blackburn AN et al. | β | 2017 | β |
| The Role of the Ghrelin System in Drug Addiction. | Zallar LJ et al. | β | 2017 | β |
| Genetic variation of the growth hormone secretagogue receptor gene is associated with alcohol use disorders identification test scores and smoking. | Suchankova P et al. | β | 2016 | β |
| Ghrelin receptor (GHS-R1A) antagonism alters preference for ethanol and sucrose in a concentration-dependent manner in prairie voles. | Stevenson JR et al. | β | 2016 | β |
| Differential effects of ghrelin antagonists on alcohol drinking and reinforcement in mouse and rat models of alcohol dependence. | Gomez JL et al. | β | 2015 | β |
| Ghrelin in psychiatric disorders - A review. | Wittekind DA et al. | β | 2015 | β |
| Ghrelin signaling is not essential for sugar or fat conditioned flavor preferences in mice. | Sclafani A et al. | β | 2015 | β |
| Ghrelin's Role in the Hypothalamic-Pituitary-Adrenal Axis Stress Response: Implications for Mood Disorders. | Spencer SJ et al. | β | 2015 | β |
| GHS-R1A antagonism reduces alcohol but not sucrose preference in prairie voles. | Stevenson JR et al. | β | 2015 | β |
| Regulation of the mesolimbic dopamine circuit by feeding peptides. | Liu S et al. | β | 2015 | β |
| Alcohol: mechanisms along the mesolimbic dopamine system. | Engel JA et al. | β | 2014 | β |
| Corticotropin releasing factor: a key role in the neurobiology of addiction. | Zorrilla EP et al. | β | 2014 | β |
| Desacyl ghrelin prevents doxorubicin-induced myocardial fibrosis and apoptosis via the GHSR-independent pathway. | Pei XM et al. | β | 2014 | β |
| "Drinking in the Dark" (DID): a simple mouse model of binge-like alcohol intake. | Thiele TE et al. | β | 2014 | β |
| Ghrelin-Derived Peptides: A Link between Appetite/Reward, GH Axis, and Psychiatric Disorders? | Labarthe A et al. | β | 2014 | β |
| Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders. | Vadnie CA et al. | β | 2014 | β |
| Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation. | Leggio L et al. | β | 2014 | β |
| Peripherally circulating ghrelin does not mediate alcohol-induced reward and alcohol intake in rodents. | Jerlhag E et al. | β | 2014 | β |
| Rewarding, reinforcing and incentive salient events involve orexigenic hypothalamic neuropeptides regulating mesolimbic dopaminergic neurotransmission. | Quarta D et al. | β | 2014 | β |
| Role of appetite-regulating peptides in the pathophysiology of addiction: implications for pharmacotherapy. | Engel JA et al. | β | 2014 | β |
| The effects of ghrelin antagonists [D-Lys(3) ]-GHRP-6 or JMV2959 on ethanol, water, and food intake in C57BL/6J mice. | Gomez JL et al. | β | 2014 | β |
| The role of ghrelin in addiction: a review. | Panagopoulos VN et al. | β | 2014 | β |
| CRF1 receptor signaling regulates food and fluid intake in the drinking-in-the-dark model of binge alcohol consumption. | Giardino WJ et al. | β | 2013 | β |
| Genetic variation of the ghrelin signalling system in individuals with amphetamine dependence. | Suchankova P et al. | β | 2013 | β |
| Ghrelin increases GABAergic transmission and interacts with ethanol actions in the rat central nucleus of the amygdala. | Cruz MT et al. | β | 2013 | β |
| Ghrelin knockout mice show decreased voluntary alcohol consumption and reduced ethanol-induced conditioned place preference. | Bahi A et al. | β | 2013 | β |
| Ghrelin receptor (GHS-R1A) antagonism suppresses both alcohol consumption and the alcohol deprivation effect in rats following long-term voluntary alcohol consumption. | Suchankova P et al. | β | 2013 | β |
| Inhibition of VTA neurons activates the centrally projecting Edinger-Westphal nucleus: evidence of a stress-reward link? | Ryabinin AE et al. | β | 2013 | β |
| The 1,2,4-triazole as a scaffold for the design of ghrelin receptor ligands: development of JMV 2959, a potent antagonist. | Moulin A et al. | β | 2013 | β |
| The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents. | Egecioglu E et al. | β | 2013 | β |
| Alcohol reward is increased after Roux-en-Y gastric bypass in dietary obese rats with differential effects following ghrelin antagonism. | Hajnal A et al. | β | 2012 | β |
| Brain reinforcement system function is ghrelin dependent: studies in the rat using pharmacological fMRI and intracranial self-stimulation. | Wellman PJ et al. | β | 2012 | β |
| Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors. | Sparrow AM et al. | β | 2012 | β |
| Characterization of Genetic Differences within the Centrally Projecting Edinger-Westphal Nucleus of C57BL/6J and DBA/2J Mice by Expression Profiling. | Giardino WJ et al. | β | 2012 | β |
| Concomitant release of ventral tegmental acetylcholine and accumbal dopamine by ghrelin in rats. | Jerlhag E et al. | β | 2012 | β |
| Ghrelin system in alcohol-dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving. | Leggio L et al. | β | 2012 | β |
| Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use. | Barson JR et al. | β | 2012 | β |
| Peptidergic Edinger-Westphal neurons and the energy-dependent stress response. | Xu L et al. | β | 2012 | β |
| Role of ghrelin in the pathophysiology of eating disorders: implications for pharmacotherapy. | Cardona Cano S et al. | β | 2012 | β |
| Stress-related neuropeptides and addictive behaviors: beyond the usual suspects. | Schank JR et al. | β | 2012 | β |
| The neurobiology of binge-like ethanol drinking: evidence from rodent models. | Sprow GM et al. | β | 2012 | β |
| Does midbrain urocortin 1 matter? A 15-year journey from stress (mal)adaptation to energy metabolism. | Kozicz T et al. | β | 2011 | β |
| Ghrelin and food reward: the story of potential underlying substrates. | Skibicka KP et al. | β | 2011 | β |
| Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice. | Jerlhag E et al. | β | 2011 | β |
| Molecular targets of alcohol action: Translational research for pharmacotherapy development and screening. | Gorini G et al. | β | 2011 | β |
| The alcohol-induced locomotor stimulation and accumbal dopamine release is suppressed in ghrelin knockout mice. | Jerlhag E et al. | β | 2011 | β |
| The extra-hypothalamic actions of ghrelin on neuronal function. | Andrews ZB | β | 2011 | β |
| The ghrelin signalling system is involved in the consumption of sweets. | Landgren S et al. | β | 2011 | β |
| Urocortin-1 within the centrally-projecting Edinger-Westphal nucleus is critical for ethanol preference. | Giardino WJ et al. | β | 2011 | β |
| Urocortin I inhibits the effects of ghrelin and neuropeptide Y on feeding and energy substrate utilization. | Currie PJ et al. | β | 2011 | β |